Search Within

Pamela Munster

Formats
  1. Journal Article (18)
  2. Meeting Abstract (12)
Groups
  1. Breast Medicine Service (27)
  2. Department of Medicine (27)
  3. Solid Tumor Oncology Division (27)
  4. GSK Faculty (18)
  5. Molecular Pharmacology and Chemistry Program Faculty (18)
  6. Sloan Kettering Institute Faculty (18)

More Groups

People
  1. Neal Rosen (18)
  2. David Solit (9)
  3. Clifford Hudis (8)
  4. Andrea Basso (7)
  5. Fuzhong Zheng (7)
  6. Larry Norton (7)

More People

Years
  1. 2003 (1)
  2. 2002 (3)
  3. 2001 (12)
  4. 2000 (6)
  5. 1999 (8)
Publications
  1. Clinical Cancer Research (10)
  2. Cancer Research (3)
  3. Cancer Investigation (2)
  4. Journal of Clinical Oncology (2)
  5. Proceedings of the American Association for Cancer Research Annual Meeting (2)
  6. Cell Biology International (1)

More Publications

Publishers
  1. American Association for Cancer Research (15)
  2. Elsevier Inc. (4)
  3. American Society of Clinical Oncology (2)
  4. Informa Healthcare (2)
  5. C M P Medica LLC * The Oncology Group (1)
  6. HMP Communications (1)

More Publishers

Results (30)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II, randomized, double-blind study of two dose levels of arzoxifene in patients with locally advanced or metastatic breast cancer
    Journal Article

    Buzdar, A.; O'Shaughnessy, J. A.; Booser, D. J.; Pippen, J. E. Jr; Jones, S. E.; Munster, P. N.; Peterson, P.; Melemed, A. S.; Winer, E.; Hudis, C.
    Journal of Clinical Oncology (2003)

    Fulltext@MSK | Save
  • Ansamycins inactivate AKT and enhances the anti-tumor effects of paclitaxel
    Meeting Abstract

    Solit, D.; Basso, A.; Munster, P.; Scher, H.; Rosen, N.
    European Journal of Cancer (2002)

    Fulltext@MSK | Save
  • 17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts
    Journal Article

    Solit, D. B.; Zheng, F. F.; Drobnjak, M.; Mùˆnster, P. N.; Higgins, B.; Verbel, D.; Heller, G.; Tong, W.; Cordon-Cardo, C.; Agus, D. B.; more...
    Clinical Cancer Research (2002)

    Fulltext@MSK | Save
  • Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2
    Journal Article

    Basso, A. D.; Solit, D. B.; Munster, P. N.; Rosen, N.
    Oncogene (2002)

    Fulltext@MSK | Save
  • Modulation of Hsp90 function by ansamycins enhances chemotherapy induced apoptosis in breast cancer cell lines in an RB and schedule dependent manner
    Meeting Abstract

    Munster, P. N.; Basso, A. D.; Solit, D.; Norton, L.; Scher, H.; Rosen, N.
    Proceedings of the American Association for Cancer Research Annual Meeting (2001)

    Fulltext@MSK | Save
  • 17-Allylamino-geldanamycin causes AKT inactivation and enhances the anti-tumor effects of paclitaxel
    Meeting Abstract

    Solit, D. B.; Basso, A. D.; Munster, P. N.; Norton, L.; Scher, H. I.; Rosen, N.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • The histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) induces differentiation of human breast cancer cells
    Meeting Abstract

    Munster, P. N.; Rosen, N.; Rifkind, R.; Marks, P.; Richon, V.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Phase I trial of 17AAG (17-allylamino) 17-demethoxygeldanamycin (17AAG) in patients (Pts) with advanced cancer
    Meeting Abstract

    Scher, H. I.; Solit, D. B.; Munster, P. N.; Tong, W. P.; Lawrence, S.; Kenneson, K.; Larson, S.; De La Cruz, A.; Reuter, V.; Rosen, N.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • [Commentary on] Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes
    Journal Article

    Munster, P.
    Women's Oncology Review (2001)

    Fulltext@MSK | Save
  • Breast cancer in the elderly
    Journal Article

    Hurria, A.; Mùˆnster, P. N.; Hudis, C. A.
    Clinical Geriatrics (2001)

    Fulltext@MSK | Save